Survey of the anti-factor IX immunoglobulin profiles in patients with hemophilia B using a fluorescence-based immunoassay-Reference-Cited by-同舟云学术

Survey of the anti-factor IX immunoglobulin profiles in patients with hemophilia B using a fluorescence-based immunoassay

Published:2016-09-17 Issue:10 Volume:14 Page:1931-1940
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Boylan B.¹,Rice A. S.¹,Neff A. T.²,Manco-Johnson M. J.³,Kempton C. L.⁴,Miller C. H.¹,

Affiliation:

1. Division of Blood Disorders; National Center on Birth Defects and Developmental Disabilities; Centers for Disease Control and Prevention; Atlanta GA USA

2. Vanderbilt University Medical Center; Nashville TN USA

3. Hemophilia and Thrombosis Center; University of Colorado and The Children's Hospital; Aurora CO USA

4. Department of Hematology/Oncology; Emory University School of Medicine; Atlanta GA USA

Funder

Pfizer Pharmaceuticals

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.13438/fullpdf

Reference38 articles.

1. Inhibitor development in haemophilia B: an orphan disease in need of attention;DiMichele;Br J Haematol,2007

2. Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors;Astermark;Haemophilia,2006

3. Immune tolerance induction in patients with severe hemophilia with inhibitors: expert panel views and recommendations for clinical practice;Benson;Eur J Haematol,2012

4. Healthcare expenditures for males with haemophilia and employer-sponsored insurance in the United States, 2008;Guh;Haemophilia,2012

5. Factor IX inhibitors and anaphylaxis in hemophilia B;Warrier;J Pediatr Hematol Oncol,1997

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Soluble expression of recombinant coagulation factor IX protein using Escherichia coli;Biochemistry and Biophysics Reports;2024-07

2. International Council for Standardization in Haematology recommendations for laboratory measurement of factor VIII and FIX type I inhibitors;International Journal of Laboratory Hematology;2023-06-07

3. Stability of specimens for use in the Centers for Disease Control and Prevention assays for factor VIII and IX inhibitors;Research and Practice in Thrombosis and Haemostasis;2022-10

4. Factor IX antibodies and tolerance in hemophilia B in the Nordic countries – The impact of F9 variants and complications;Thrombosis Research;2022-09

5. Blood pressure in persons with haemophilia with a focus on haemophilia‐specific risk factors;Haemophilia;2022-06-29